Key Highlights

  • Metir plc (LSE:MET) fell 8.33% on 7 October 2026, adding to losses of around 50% in the week after its interim results.
  • Half-year Revenue fell to £367,000 from £919,000, while the adjusted EBITDA loss widened to £512,000.
  • The board said a fundraise remains an acute priority and warned that failure to raise Capital could lead to an Insolvency process.
  • Handover of a 27-unit water toxicity monitoring project in Qatar is expected in the fourth quarter, unlocking recurring consumables revenue.
  • Metir's PFAS detection technology has gained early traction, including a sale to Veralto and a collaboration with Puraffinity for semiconductor applications.

Metir Share Price Falls on the FTSE AIM All-Share

Shares in Metir plc (LSE:MET), the water and environmental monitoring technology group listed on AIM and part of the FTSE AIM All-Share, fell 8.33% on Wednesday, 7 October 2026. The decline extended a severe sell-off that began on 28 September, when the shares fell 46% to 0.35p on the day of the company's interim results, ending that week roughly 50% lower.

Why Metir Stock Moved Down

The dominant Factor is the going-concern disclosure in the interim results. Management stated that a fundraising remains an acute priority and warned that failure to secure new capital could lead to an insolvency process. For investors, such language is a clear warning that the company's survival depends on raising money soon, and that any raise is likely to be priced at a deep discount to the prevailing share price.

The second factor is the sharp fall in revenue. For the six months to 30 June 2026, revenue was £367,000, down from £919,000 a year earlier. The decline reflected lower equipment sales and a temporary interruption to production of the company's QuickChek sulphate reducing bacteria test kits. Adjusted EBITDA showed a loss of £512,000, compared with a loss of £261,000 a year earlier, and the board expects full-year 2026 revenue to be lower than in 2025.

The third factor is geopolitical disruption. Metir cited the Middle East conflict as a cause of delays to the completion of its 27-unit continuous toxicity monitoring project in Qatar and to reagent sales. Renewed tension in the Strait of Hormuz on 7 October, which also pushed the FTSE 100 lower, is a reminder that the company's most important near-term revenue source sits in a sensitive region.

The Qatar Project

In July 2026, Metir received written confirmation that the Qatar state utility, Kahramaa, intends to run the water toxicity monitoring project for at least 10 years. The confirmation, delivered through regional partner Avanceon, also set out an intention to open a tender for a second phase of 17 additional units, which would take the installed base to 44. Metir's Modern Water division is the sole supplier of the technology, which continuously screens water supplies for thousands of potential toxins and issues alerts within minutes.

The company expects handover of the first phase in the fourth quarter of 2026, after which the existing 27 units should generate around £30,000 per month in consumables revenue, as the reagent used in the units is replaced every 30 days. If the second phase proceeds, Recurring Revenue could rise above £50,000 per month.

PFAS Detection Opportunity

Metir's Microsaic Systems Business has developed a rapid PFAS detector that addresses one of the fastest-growing areas of water regulation. In June 2026, Nasdaq-listed water quality group Veralto purchased a PFAS detector, providing early commercial validation. In September, Metir teamed up with UK water technology company Puraffinity to test a detect, treat and verify system for semiconductor manufacturing, and Swansea University's Centre for Integrative Semiconductor Materials is using a Microsaic PFAS detector to monitor waste streams. Metir also appointed Streamline Hydro as distributor for its Modern Water products in Australia and New Zealand and signed a memorandum of understanding with Portsmouth Aviation in July to evaluate integrated water treatment and monitoring systems.

Why Investors Are Watching LSE:MET

Metir combines toxicity monitoring, PFAS analytics and pathogen detection, a portfolio aligned with tightening global water regulation. The technology story is credible, but the Balance Sheet is the immediate concern. Investors want to see whether the company can complete a fundraise on terms that allow it to reach the recurring revenue expected from Qatar and to commercialise PFAS detection.

What to Watch Next

  • Announcement of a fundraise and its size, pricing and participants.
  • Confirmation of the Qatar phase one handover in the fourth quarter.
  • Progress on the tender for the 17-unit second phase in Qatar.
  • Further PFAS detector sales and Partnership milestones.

Bottom Line

The 8.33% fall in Metir plc (LSE:MET) reflects ongoing concern after a going-concern warning, a steep drop in half-year revenue and the risk of a heavily discounted fundraise. On the FTSE AIM All-Share, the company's future depends on raising capital quickly enough to reach the recurring revenue expected from its Qatar contract and to scale its PFAS technology.